A carregar...
Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia
Although imatinib is an effective treatment for chronic myelogenous leukemia (CML), and nearly all patients treated with imatinib attain some form of remission, imatinib does not completely eliminate leukemia. Moreover, if the imatinib treatment is stopped, most patients eventually relapse (Cortes e...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3862185/ https://ncbi.nlm.nih.gov/pubmed/20532990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11538-010-9553-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|